Viralmyocarditis
Conditions
Interventions
Experimental group:Yuping Linglu Fang:Milkvetch Root 30g, Largehead Atractylodes Rh 10g,Radix Saposhnikoviae Divaricatae 10g,Ganoderma 20g,Pyrolae Herba 20g
Control group:Placebo:Milkvetch Root 6g, Largehead Atractylodes Rh 2g,Radix Saposhnikoviae Divaricatae 2g,Ganoderma 4g,Pyrolae Herba 4g
Sponsors
Affiliated Hospital of Shanxi University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Diagnostic criteria of Western Medicine: The diagnostic criteria for coronavirus disease 2019(COVID-19) refer to issued by the National Health Commission and the People's Republic of China and the National Administration of Traditional Chinese Medicine. 1.Clinical manifestations related to coronavirus disease 2019. 2.Have one or more of the following etiological and serological examination results: (1)Positive for coronavirus nucleic acid test. (2)Positive coronavirus antigen test. (3)Positive isolation and culture of the new coronavirus. (4)Convalescent levels of new coronavirus-specific IgG antibodies are 4 times or more higher than those in the acute phase. Diagnostic criteria of traditional Chinese medicine: According to the clinical application evaluation research of "Guidelines for Diagnosis and Treatment of Common Diseases in Traditional Chinese Internal Medicine " and relevant literature, the diagnostic criteria for qi and yin deficiency. (1)Main symptoms: heart palpitations, chest tightness of breath, discomfort or pain in the precordial area, shortness of breath, fatigue. (2)Secondary symptoms: dizziness, sweating, dry mouth and drink less, pale tongue, sharp red, less fur or peeling off; Pulse fineness, weakness or nodule generation, etc. (3)History of viral infection before onset. With 2 main symptoms, or 1 main symptom and 2 secondary symptoms, it can be diagnosed in combination with the medical history. Inclusion Criteria: (1)Meet the diagnostic criteria of Western Medicine. (2)Meet the diagnostic criteria of TCM syndrome (qi and Yin deficiency syndrome). (3)Genders are not limited, and the age is between 18-60 years old. (4)Signed informed consent will be voluntarily. All conform to the standards in article 4, at the same time can be incorporated into the research object, as the case.
Exclusion criteria
Exclusion criteria: (1)Patients with coronary heart disease, infective endocarditis and heart valve disease;With severe renal insufficiency, blood system damage, mental disease, malignant tumors, infections, diabetes, gout, hyperthyroidism, bronchial asthma and severe respiratory system diseases, etc. (2)Patients with autoimmune diseases and immunodeficiency. (3)Pregnant or lactating women. (4)Patients with other diseases and taking drugs affect the test. (5)The test drug suspect or clear allergy. (6)Nearly 2 months to other researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Th17 /Treg; | — |
Countries
China
Contacts
Public ContactZhigeng Hu
Affiliated Hospital of Shanxi University of Chinese Medicine
Outcome results
None listed